Toward development of a point-of-care assay of enoxaparin anticoagulant activity in whole blood
✍ Scribed by Mario A. Inchiosa; Suryanarayana Pothula; Keshar Kubal; Vajubhai T. Sanchala; Iris Navarro
- Publisher
- Springer US
- Year
- 2011
- Tongue
- English
- Weight
- 430 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0929-5305
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
A multivariate assay was developed for detecting lymphoproliferative responses to rotavirus in whole blood and breast milk. Detection of lymphocyte transformation in samples from healthy uninfected adults required an assay incorporating a large number of antigen and cell concentrations and several i
## Abstract Ethylenediaminetetraacetic acid (EDTA) is the anticoagulant recommended for full blood counts, citrate is recommended for coagulation and platelet studies, and citrate‐theophylline‐adenosine‐dipyridamole (CTAD) inhibits platelet activation. Because the combination of EDTA and CTAD (E/C)